A. M. Mahedi Hasan

A. M. Mahedi Hasan

Auto-generated profile, based on publicly available information

A. M. Mahedi Hasan

University College London Cancer Institute, London, UK

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2012 in Communicative & Integrative Biology
Verified
Journal Article
Open access
SSSazia Sharmin
Sazia Sharmin
MAMuhammad Shafiul Azam
Muhammad Shafiul Azam
MIMd. Shahidul Islam
Md. Shahidul Islam
ASAbu Sajib
Abu Sajib
NMNiaz Mahmood
Niaz Mahmood
HKHaseena Khan
Haseena Khan
Two of the most widely and intensively cultivated jute species, Corchorus capsularis and Corchorus olitorius, suffer severely from a stem rot disease caused by the fungus Macrophomina phaseolina. W...

10 August 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
AHA. M. Mahedi Hasan
A. M. Mahedi Hasan
PCPaolo Cremaschi
Paolo Cremaschi
DWDaniel Wetterskog
Daniel Wetterskog
AJAnuradha Jayaram
Anuradha Jayaram
SWStephen Q. Wong
Stephen Q. Wong
GAGerhardt Attard
Gerhardt Attard
Despite initial responses to hormone treatment, metastatic prostate cancer invariably evolves to a lethal state. To characterize the intra-patient evolutionary relationships of metastases that evade treatment, we perform genome-wide copy number profiling and bespoke approaches targeting the androgen receptor (AR) on 167 metastatic regions from 11 organs harvested post-mortem from 10 men who died from prostate cancer. We identify diverse and patient-unique alterations clustering around the AR in metastases from every patient with evidence of independent acquisition of related genomic changes within an individual and, in some patients, the co-existence of AR-neutral clones. Using the genomic boundaries of pan-autosome copy number changes, we confirm a common clone of origin across metastases and diagnostic biopsies, and identified in individual patients, clusters of metastases occupied by dominant clones with diverged autosomal copy number alterations. These autosome-defined clusters are characterized by cluster-specific AR gene architectures, and in two index cases are topologically more congruent than by chance (p-values 3.07 × 10−8 and 6.4 × 10−4). Integration with anatomical sites suggests patterns of spread and points of genomic divergence. Here, we show that copy number boundaries identify treatment-selected clones with putatively distinct lethal trajectories.

22 February 2023 in Research Square
Verified
Preprint
Open access
PDF file
AHA M Mahedi Hasan
A M Mahedi Hasan
PCPaolo Cremaschi
Paolo Cremaschi
DWDaniel Wetterskog
Daniel Wetterskog
AJAnuradha Jayaram
Anuradha Jayaram
SWStephen Q Wong
Stephen Q Wong
GAGerhardt Attard
Gerhardt Attard
Despite initial responses to hormone treatment, metastatic prostate cancer invariably evolves to a lethal state. To characterize the intra-patient relationships of metastases that evade treatment, we performed genome-wide copy number profiling and bespoke approaches targeting the androgen receptor (AR) on 142 metastatic regions from 10 organs harvested post-mortem from nine men who died from prostate cancer. We identified diverse and patient-unique alterations clustering around the AR in metastases from every patient with evidence of independent acquisition of related genomic changes within an individual and, in some patients, the co-existence of AR-neutral clones. Using the genomic boundaries of pan-autosome copy number change, we confirmed a common clone of origin across metastases and diagnostic biopsies; and identified in individual patients, clusters of metastases occupied by dominant clones with diverged autosomal copy number alterations and cluster-specific AR gene architectures. Copy number boundaries identified treatment-selected clones with distinct lethal trajectories.

3 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AHA M Mahedi Hasan
A M Mahedi Hasan
PCPaolo Cremaschi
Paolo Cremaschi
DWDaniel Wetterskog
Daniel Wetterskog
AJAnuradha Jayaram
Anuradha Jayaram
SWStephen Q Wong
Stephen Q Wong
GAGerhardt Attard
Gerhardt Attard
Despite initial responses to hormone treatment, metastatic prostate cancer invariably evolves to a lethal state. To characterize the intra-patient relationships of metastases that evade treatment, we performed genomewide copy number profiling and bespoke approaches targeting the androgen receptor (AR) on 142 metastatic regions from 10 organs harvested post-mortem from nine men who died from prostate cancer. We identified diverse and patient-unique alterations clustering around the AR in metastases from every patient with evidence of independent acquisition of related genomic changes within an individual and, in some patients, the co-existence of AR -neutral clones. Using the genomic boundaries of pan-autosome copy number change, we confirmed a common clone of origin across metastases and diagnostic biopsies; and identified in individual patients, clusters of metastases occupied by dominant clones with diverged autosomal copy number alterations. Autosome-defined clusters were characterized by cluster-specific AR gene architectures that in two index cases were topologically more congruent than by chance ( p -values 0.03, 3.07×10 -8 ). Integration with anatomical site suggested patterns of spread and points of genomic divergence. Copy number boundaries identified treatment-selected clones with putatively distinct lethal trajectories. Statement of significance: Lethal prostate cancer evolves from a single clone of origin and upon a treatment-mediated selection, progresses to lethal disease via a limited number of related clones harboring patient-unique androgen receptor gene architectures.